These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29609684)

  • 1. Synthesis and biological evaluation of novel 2 (4`-hydroxynaphthyl) chromen-4-one as a CK2 inhibitor.
    Haidar S; Jabbour M; Al-Khayat MA; Aichele D; Jose J
    Pharmazie; 2018 Apr; 73(4):191-195. PubMed ID: 29609684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of new embelin derivatives as CK2 inhibitors.
    Oramas-Royo S; Haidar S; Amesty Á; Martín-Acosta P; Feresin G; Tapia A; Aichele D; Jose J; Estévez-Braun A
    Bioorg Chem; 2020 Jan; 95():103520. PubMed ID: 31887475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR Model of Indeno[1,2-
    Haidar S; Marminon C; Aichele D; Nacereddine A; Zeinyeh W; Bouzina A; Berredjem M; Ettouati L; Bouaziz Z; Le Borgne M; Jose J
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31888043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2.
    Guillon J; Le Borgne M; Rimbault C; Moreau S; Savrimoutou S; Pinaud N; Baratin S; Marchivie M; Roche S; Bollacke A; Pecci A; Alvarez L; Desplat V; Jose J
    Eur J Med Chem; 2013 Jul; 65():205-22. PubMed ID: 23711832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and in Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2.
    Haidar S; Aichele D; Birus R; Hielscher J; Laitinen T; Poso A; Jose J
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30965682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines.
    Ostrynska OV; Balanda AO; Bdzhola VG; Golub AG; Kotey IM; Kukharenko OP; Gryshchenko AA; Briukhovetska NV; Yarmoluk SM
    Eur J Med Chem; 2016 Jun; 115():148-60. PubMed ID: 27017545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of 3-quinoline carboxylic acids as new inhibitors of protein kinase CK2.
    Syniugin AR; Ostrynska OV; Chekanov MO; Volynets GP; Starosyla SA; Bdzhola VG; Yarmoluk SM
    J Enzyme Inhib Med Chem; 2016; 31(sup4):160-169. PubMed ID: 27590574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and characterization of synthetic 4'-hydroxyflavones-New CK2 inhibitors from flavone family.
    Golub AG; Bdzhola VG; Ostrynska OV; Kyshenia IV; Sapelkin VM; Prykhod'ko AO; Kukharenko OP; Yarmoluk SM
    Bioorg Med Chem; 2013 Nov; 21(21):6681-9. PubMed ID: 24011954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 2,6-di(furan-3-yl)anthracene-9, 10-dione as an inhibitor of human protein kinase CK2.
    Haidar S; Meyers A; Bollacke A; Jose J
    Pharmazie; 2015 Dec; 70(12):772-6. PubMed ID: 26817273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new family of densely functionalized fused-benzoquinones as potent human protein kinase CK2 inhibitors.
    Martín-Acosta P; Haider S; Amesty Á; Aichele D; Jose J; Estévez-Braun A
    Eur J Med Chem; 2018 Jan; 144():410-423. PubMed ID: 29288942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel CK2 leads by cross-docking based virtual screening.
    Sun H; Wu X; Xu X; Jiang Z; Liu Z; You Q
    Med Chem; 2014; 10(6):628-39. PubMed ID: 24286395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based identification of novel CK2 inhibitors with a linear 2-propenone scaffold as anti-cancer agents.
    Qi X; Zhang N; Zhao L; Hu L; Cortopassi WA; Jacobson MP; Li X; Zhong R
    Biochem Biophys Res Commun; 2019 Apr; 512(2):208-212. PubMed ID: 30878184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitors.
    Chekanov MO; Ostrynska OV; Synyugin AR; Bdzhola VG; Yarmoluk SM
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):338-43. PubMed ID: 23578312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening.
    Nakanishi I; Murata K; Nagata N; Kurono M; Kinoshita T; Yasue M; Miyazaki T; Takei Y; Nakamura S; Sakurai A; Iwamoto N; Nishiwaki K; Nakaniwa T; Sekiguchi Y; Hirasawa A; Tsujimoto G; Kitaura K
    Eur J Med Chem; 2015; 96():396-404. PubMed ID: 25912672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-substituted Indole-2 and 3-carboxamide derivatives as inhibitors of human protein kinase CK2: in vitro assay and molecular modelling study.
    Olgen S; Gratz A; Kurt ZK; Jose J
    Acta Chim Slov; 2013; 60(3):628-35. PubMed ID: 24169717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of a novel class of CK2 inhibitors: application of copper- and gold-catalysed cascade reactions for fused nitrogen heterocycles.
    Suzuki Y; Oishi S; Takei Y; Yasue M; Misu R; Naoe S; Hou Z; Kure T; Nakanishi I; Ohno H; Hirasawa A; Tsujimoto G; Fujii N
    Org Biomol Chem; 2012 Jul; 10(25):4907-15. PubMed ID: 22610034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel chiral TBBt derivatives with hydroxyl moiety. Studies on inhibition of human protein kinase CK2α and cytotoxicity properties.
    Borowiecki P; Wawro AM; Wińska P; Wielechowska M; Bretner M
    Eur J Med Chem; 2014 Sep; 84():364-74. PubMed ID: 25036794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel class of selective CK2 inhibitors targeting its open hinge conformation.
    Dalle Vedove A; Zonta F; Zanforlin E; Demitri N; Ribaudo G; Cazzanelli G; Ongaro A; Sarno S; Zagotto G; Battistutta R; Ruzzene M; Lolli G
    Eur J Med Chem; 2020 Jun; 195():112267. PubMed ID: 32283296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of dual kinase inhibitors of CK2 and GSK3β: combined qualitative and quantitative pharmacophore modeling approach.
    Pardhi T; Vasu K
    J Biomol Struct Dyn; 2018 Jan; 36(1):177-194. PubMed ID: 27960601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.